VHL and neoplasm: Regarding tumor surveillance for VHL-associated PPGL, the VHL Alliance recommends annual plasma-free metanephrine or urinary-fractionated metanephrine monitoring from 5 years of age, abdominal MRI every 2 years from the age of 15 years, and annual blood pressure and pulse monitoring from 2 years of age [17].